Chiara Dalle Fratte

The Genotype for <i><scp>DPYD</scp></i> Risk Variants in Patients With Colorectal Cancer and the Related Toxicity Management Costs in Clinical Practice

Giuseppe Toffoli, Federico Innocenti, Jerry Polesel et al. · Clinical Pharmacology & Therapeutics · 2018 · 50 citations

Estimating the Effectiveness of DPYD Genotyping in Italian Individuals Suffering from Cancer Based on the Cost of Chemotherapy-Induced Toxicity

Vasileios Fragoulakis, Rossana Roncato, Chiara Dalle Fratte et al. · The American Journal of Human Genetics · 2019 · 49 citations · Full text

Dpyd Genotyping, Oncology, Cancer Management +8

Longitudinal therapy monitoring of ALK-positive lung cancer by combined copy number and targeted mutation profiling of cell-free DNA

Steffen Dietz, Petros Christopoulos, Zhao Yuan et al. · EBioMedicine · 2020 · 41 citations · Full text

<i>CYP2D6</i> and <i>CYP2C8</i> pharmacogenetics and pharmacological interactions to predict imatinib plasmatic exposure in GIST patients

Chiara Dalle Fratte, Sara Gagno, Rossana Roncato et al. · British Journal of Clinical Pharmacology · 2022 · 12 citations · Full text

Clonal Selection of a Novel Deleterious TP53 Somatic Mutation Discovered in ctDNA of a KIT/PDGFRA Wild-Type Gastrointestinal Stromal Tumor Resistant to Imatinib

Chiara Dalle Fratte, Michela Guardascione, Elena De Mattia et al. · Frontiers in Pharmacology · 2020 · 11 citations · Full text